PSGL-1

PSGL-1

PSGL-1 Informations sur la molécule

Molecule Name
P-selectin glycoprotein ligand-1
Alias de la molécule
PSGL1,CD162,SELPLG,Selectin P ligand
Drug Development Progress
Nombre de médicaments cliniques4
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
P-selectin glycoprotein ligand 1,PSGL-1,SELPLG,Selectin P Ligand,Cutaneous Lymphocyte-Associated Associated Antigen,CD162 Antigen,CD162,PSGL1,CLA
Contexte de la molécule
P-selectin glycoprotein ligand 1 (PSGL-1) is also known as Selectin P ligand (SELPLG), CD antigen CD162. PSGL-1 is disulfide-linked homodimer which is the high affinitycounter-receptor for P-selectin on expressed on activated endothelial cells and platelets. PSGL-1 / SELPLG interacts with P-, E- and L-selectins, through their lectin/EGF domains, is required for promoting recruitment and rolling of leukocytes. These interactions require sialyl Lewis X glycan modification but there is a differing dependence for tyrosine sulfations. Dimerization appears not to be required for P-selectin/SELP binding. PSGL-1 can interact with SNX20, MSN and SYK. PSGL-1 / SELPLG mediate the activation of SYK by SELPLG.

PSGL-1 Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
CepeprubartSelK-2Phase 2 ClinicalSelexys
Asthma; Pulmonary Disease, Chronic Obstructive; Venous Thromboembolism
Details
LeiolizumabAbGn 168H2; AbGn-268; AbGn-168H2; ALTB-268Phase 2 ClinicalAltrubio Inc
Arthritis, Psoriatic; Colitis, Ulcerative
Details
NeihulizumabAbGn-168; AbGn-168H; ALTB-168Phase 1 ClinicalAltrubio Inc
Arthritis, Psoriatic; Colitis, Ulcerative; Graft vs Host Disease; Plaque psoriasis; Psoriasis
Details
SSGJ-617SSGJ-617; SSGJ617; 61X; VTX-0811; 617Phase 1 ClinicalVerseau Therapeutics Inc
Solid tumours
Details